Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BELITE-BIO-INC-136829476/news/Belite-Bio-Announces-PMDA-Submission-of-Tinlarebant-for-Stargardt-Disease-Clinical-Trial-in-Japan-46263487/?utm_source=whatsapp&utm_medium=social&utm_campaign=share